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Introduction
Successful onset and maintenance of pregnancy meets a potential quandary, as the implanting blastocyst is semiallogeneic. Hence, the maternal immune system has to recognize the developing child as 'self' and/or to build immune tolerance in order to allow invasion of such semiallogeneic tissue instead of rejecting it. Well-orchestrated adaptation processes of the maternal immune system to the fetus at local and systemic levels have been proposed, which are capable of ensuring immunotolerance and successful pregnancy. These processes range from innate responses such as natural killer cells and dendritic cells to adaptive responses such as increasing numbers of regulatory T cells. (Aluvihare et al., 2004; Clark, 2003; Tafuri et al., 1995; Zhou and Mellor, 1998) .
Among several candidate immunoregulators, T-helper type 1 (Th1)-type cytokine interferon-c (IFN-c) is intensely discussed to elicit pathways which are involved in tolerance induction Liu and Janeway, 1990; Schroecksnadel and Fuchs, 2006; Wood and Sawitzki, 2006) . Pro-inflammatory stimuli like IFN-c are the primary inducers of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) and of neopterin biosynthesis by GTPcyclohydrolase in human monocyte-derived macrophages and dendritic cells ( Figure 1 ) (Huber et al., 1984; Weiss et al., 1999; Wirleitner et al., 2002) . During murine pregnancy, activation of IDO was demonstrated as a necessary requirement for maternal tolerance induction (Munn et al., 1998) , whereby it is still hotly debated why IDO knockout mice do not show an impaired reproductive fitness. During human pregnancy, the maternal decidua and the fetal syncytiotrophoblast, which invades the uterus, express IDO and this expression at the feto-maternal interface may prevent immunological rejection of the fetus by suppression of T cell responsiveness (Kamimura et al., 1991; Mellor and Munn, 2001; Munn et al., 1998) .
Earlier studies show that tryptophan degradation and neopterin formation are increased in pregnant women, indicating activation of IDO under immunological control mechanisms. Human pregnancy was found to be associated with increasing serum and urine neopterin concentrations correlating with the gestational age and rather quickly returning to normal after birth (Bichler et al., 1983; Schroecksnadel et al., 1996; Schroecksnadel et al., 2003) . It is assumed that immune recognition and response is induced in early pregnancy. However, insights supporting the role of neopterin and tryptophan metabolism during early pregnancy -before a gestational age of 12 weeks -are still sparse.
The aim of the present study was to analyse urinary concentrations of neopterin in women undergoing assisted reproductive technologies to obtain information about changes of the immune system during the first 2 weeks of pregnancy. Such insights would then allow the identification of early markers/predictors for successful blastocyst implantation after treatment.
Materials and methods

Patients
Urinary neopterin concentrations from the very early phase of pregnancy were determined in 61 women (average age 33 years, range 24-41 years) after day-5 (blastocyst stage) transfer in-vitro fertilization (IVF, n = 13) or intracytoplasmic sperm injection (ICSI, n = 59). Women were asked to collect early morning urine specimens daily over 14 days, starting the day after the IVF or ICSI, and kept in the freezer at À20°C until measured. In total, 72 fertilization attempts were followed. For three individuals, urine collections were available during a longer period of pregnancy. During the study period, women did not show any evidence of systemic illness or fever.
The study was in accordance with the Helsinki declaration and all individuals included in the study gave informed consent that the results of urinary neopterin measurements were solely used for scientific purposes in a blinded manner.
Neopterin measurement
Determination of neopterin was performed using HPLC on reversed-phase C18 with Sörensen potassium phosphate buffer (0.015 mol/l, pH = 6.4) as eluent (flow rate = 1.0 ml/ min) (Schroecksnadel et al., 2006a,b) as follows: 100 ll urine were mixed with 1000 ll elution buffer containing 2 g/l EDTA to dissolve eventual urinary sediments. Neopterin was detected by measurement of its natural fluorescence (excitation wavelength 353 nm, emission wavelength 438 nm). Physiological differences in urine densities were taken into account by calculating the ratio of neopterin versus creatinine concentrations, which were measured in parallel to neopterin in the same chromatographic run by detection of its UV absorption at 235 nm wavelength. The quotients neopterin/creatinine were expressed in lmol neopterin/ mol creatinine. 
Statistical analysis
Not all the study participants completed collection of urine specimens throughout the whole observation period of 2 weeks. There was an increasing number of missing specimens at the later days of the follow-up; during days 11-14, drop-out number of participants was from two to five in the pregnant group and from eight to 16 in the non-pregnant group. Consequently, group comparisons were only performed for the first 10 days in which the number of missing specimens was zero in the pregnant group and four or more in the non-pregnant group (Figure 2) .
Because not all the data sets showed normal distribution, non-parametric statistics were applied for data analyses. For comparison of grouped data, Friedman test and Wilcoxon signed ranks test were used. In order to compare serial measurements between pregnant and non-pregnant women, urinary neopterin concentrations were plotted versus time (not shown). Thereby it was concluded that the variable changed during the observation period in a rather linear way and, thus, the slopes of regression lines fitted to the data of each individual by least square estimation were compared between the two groups by non-parametric Mann-Whitney U-test (Matthews et al., 1990) .
Statistical Package for the Social Sciences version 14 (SPSS, Chicago, IL, USA) was used. P-values below 0.05 were considered to indicate significant differences.
Results
Among the 72 attempts of assisted reproduction treatment, 20 were successful (28%) and resulted in a viable pregnancy, five after IVF and 15 after ICSI. Four women had a multiple pregnancy (three twins, one triplets) and four experienced abortion at a later time during follow-up. On day 1, neopterin concentrations in women who later became pregnant (mean ± SEM 160 ± 13.3 lmol/mol creatinine) were slightly lower than in women who did not (mean ± SEM 182 ± 10.0 lmol/mol creatinine), this difference was however not significant. A significant increase of neopterin concentrations was observed in the group of pregnant women (chi-squared = 23.291, P < 0.01; Friedman test) but not in the non-pregnant group (chi-squared = 8.203, not significant; Friedman test). When percentage changes were compared after setting baseline values of individual women as 100%, the percentage change of concentrations was highest on day 9 with 121 ± 9.1% in pregnant women versus 105 ± 6.2% in non-pregnant women (Figure 2) . Likewise, when compared with baseline, the increase of neopterin concentrations became significant from day 4 onwards in the pregnant women (U = 2.083, P < 0.05, paired rank test). In women with twin or triplet pregnancies, neopterin concentrations were only slightly higher as compared with single pregnancies (details not shown).
On comparing the slopes of regression lines fitted to urinary neopterin values plotted versus time there was a stronger increase of urinary neopterin in pregnant (median slope 1.413, 95% CI À0.576 to 4.308) than in non-pregnant women (median slope À1.275, 95% CI À2.897 to 0.886; U = 258, P < 0.021).
In two individuals, neopterin analyses were possible throughout the first 70 and 80 days respectively of pregnancy. Further, samples were obtained from one woman throughout the entire pregnancy and during puerperium. In the first two cases, this study observed that neopterin concentrations continued to steadily increase with time reaching concentrations of approximately 350 and 225 lmol/mol creatinine, and in the third women neopterin concentrations around 400 lmol/mol creatinine were reached at the end of pregnancy, including a few peaks around day 60 of pregnancy (details not shown). In one female post-partum measurements were available, and Caesarean section was performed as was requested by the mother, because of an intrauterine death during her previous pregnancy. After Caesarean section was performed, neopterin concentrations abruptly declined but again two prominent peaks were observed within the following month.
Discussion
Despite the intensive research performed over previous years, immunotolerance in pregnancy is still far from being fully understood, and it has been estimated that the implantation of more than 50% of conceptions in humans is unsuccessful (Clark, 2003) . A better understanding of the mechanisms involved in maternal pregnancy maintenance would provide the basis for developing suitable therapeutic and predictive tools for this condition. In the present study, an increase of urinary neopterin concentrations was observed in women as early as 4 days after treatment in successfully progressing pregnancies. An increase of neopterin concentrations was seen preferentially in early pregnancy but not in women who did not become pregnant. It indicates pro-inflammatory pathways caused by pregnancy which most probably involve immune system activation and production of IFN-c. No other explanation (e.g. infections) was evident, which could explain the raise of neopterin concentrations in the later days. Thus, the increase of neopterin would be in line with a role of IFN-c in tolerance induction, as was previously suggested several times Liu and Janeway, 1990; Wood and Sawitzki, 2006) . Thereby the activation of IDO could play an important role, although it may represent just one of the major players induced by the cytokine and being able to induce specific immunotolerance (Wood and Sawitzki, 2006) . Notably, only humans and mice produce larger amounts of neopterin because their monocyte-derived cells like macrophages or dendritic cells are deficient for the enzyme pyruvoyl tetrahydropterin synthase, which in other cells and cells of other species including macrophages converts 7,8-dihydroneopterintriphophate to 5,6,7,8-tetrahydrobiopterin, the cofactor of amino acid hydroxylases including nitric oxide synthases. So monitoring of neopterin concentrations cannot be applied as a urine pregnancy test in mouse biology.
In vitro and in vivo, tryptophan degradation by IDO is strongly induced by pro-inflammatory cytokines such as IFN-c in a broad variety of cells in humans and other species (Byrne et al., 1986; Werner-Felmayer et al., 1989; Wirleitner et al., 2002; Yoshida et al., 1981) . Interestingly, in the endometrium and decidua, IFN-c is largely derived from decidual natural killer (dNK) cells. This cell population is increasingly acknowledged to control trophoblast invasion and vascular remodelling through their professional ability to secrete an array of angiogenesis-regulating molecules, chemokines and cytokines, such as vascular endothelial growth factor, placental growth factor and interleukin-8 (Hanna et al., 2006) . Hence, the up-regulation of neopterin ensuring subsequent successful blastocyst implantation might be an additional task of this unique decidual cell population. IFN-c strongly induces GTP-cyclohydrolase I and gives rise to the secretion of neopterin in human and primate monocyte-derived macrophages and dendritic cells (Figure 1) (Huber et al., 1984; Munn et al., 1998; Murr et al., 2002) . As dNK cells and dendritic cells have been postulated to promote pregnancy maintenance by forming an immunological synapse (Karimi et al., 2008) , increasing neopterin production associated with successful pregnancy production may be mutually ensured within this synapse via dNK cell-and dendritic cell-dependent pathways.
In humans with inflammatory conditions, a close association exists between neopterin concentrations and the kynurenine-to-tryptophan ratio, which is a suitable index of tryptophan degradation (Schroecksnadel et al., 2006a,b) . It is generally assumed that pro-inflammatory cytokines like IFN-c might induce IDO in parallel to neopterin formation, and it thus could be important for the induction of tolerance in the early phase of pregnancy (Kamimura et al., 1991; Mellor and Munn, 2001; Zhou and Mellor, 1998) . A weak correlation between the serum kynurenine to tryptophan ratio, an estimate of IDO activity, and IFN-c concentrations was described recently in first-trimester gestation (Barrientos et al., 2009 ). However, because treatment was performed in women who had not previously become pregnant naturally, results of this study may not adequately reflect a normal pregnancy. Certainly, one cannot exclude that neopterin and tryptophan metabolism may have behaved differently in this particular selection of women who were included in this study.
Accumulating data suggest that alterations in the balance of Th1 to Th2 type cells and cytokines are important in immune regulation during pregnancy (Clark et al., 2005) . Whereas investigations on the cellular level often were inconclusive (Palfi et al., 1999) , this study's results are able to extend the ongoing discussion that an initial pro-inflammatory response, as is indicated by increasing neopterin concentrations, might be required for pregnancy development and/or blastocyst differentiation, as no such response was evident in women who did not become pregnant with assisted reproduction treatment. Also, this initial immune response may be involved in creating a microenvironment which prevents fetal survival. It is reasonable to speculate that, e.g., the IDO expression which was found to be required for induction of tolerance is initially cytokine induced. Unfortunately, such data on IDO activity and tryptophan degradation were not available in this study since ethical constraints excluded daily blood withdrawal. Still in accordance with findings from murine pregnancy, IDO could be related to this study's findings on higher neopterin production rates in pregnant versus non-pregnant women after treatment, but notably, there are several other pathways which are considered to be related to tolerance induction and at last some of which are induced by proinflammatory stimuli such as IFN-c. These pathways seem to reflect the down-regulatory and anti-inflammatory activities which are directed to dampen an immune response once activated Wood and Sawitzki, 2006) . Thus, the balance between pro-and anti-inflammatory cytokine pathways may be important for the fate of the fetus.
Similar pathways seem to exist with regard to the development of immunodeficiency in chronic diseases which are associated with inflammation and immune activation such as chronic infections or malignancy Murr et al., 2002) . In these patients, increased neopterin concentrations have been described earlier to parallel disease progression and to indicate a higher risk of death which is most probably associated with immune system failure Schroecksnadel and Fuchs, 2006; Wood and Sawitzki, 2006) . Neopterin concentrations were also documented throughout longer periods of gestation in two women and throughout the entire gestational length in one woman and steadily increasing neopterin concentrations until delivery were found. The steady increase of neopterin throughout the first 3 months of pregnancy was interrupted by a few spikes, which were seen in all three cases and most impressive around days 55-70. They were unrelated to clinically overt infectious episodes. However, serological analyses were not available. Thus, it remains to be identified in continuing studies whether these spikes are related to specific developmental phases during pregnancy.
In conclusion, this study describes an early increase of urinary neopterin concentrations in women who underwent successful assisted reproduction treatment compared with women without pregnancy. Assisted reproduction treatment may not represent an adequate model to extrapolate the findings to normal human pregnancy, but results should provide a further basis for a discussion on the role of proinflammatory stimuli in the induction of immunotolerance, which is required for successful nidation. Mean values of neopterin concentrations differed significantly between women with successful or unsuccessful interventions, and future research is needed to confirm: (i) whether neopterin monitoring allows early detection of pregnancy development in women after assisted reproduction treatment; and (ii) how neopterin concentrations and IDO activity might be up-regulated to allow successful blastocyst implantation.
